ATE502644T1 - Verwendung von kollagen-hydrolysat zur reduktion der viskosität einer guarkernmehl enthaltenden zusammensetzung - Google Patents

Verwendung von kollagen-hydrolysat zur reduktion der viskosität einer guarkernmehl enthaltenden zusammensetzung

Info

Publication number
ATE502644T1
ATE502644T1 AT03759947T AT03759947T ATE502644T1 AT E502644 T1 ATE502644 T1 AT E502644T1 AT 03759947 T AT03759947 T AT 03759947T AT 03759947 T AT03759947 T AT 03759947T AT E502644 T1 ATE502644 T1 AT E502644T1
Authority
AT
Austria
Prior art keywords
viscosity
reducing
composition containing
guar gum
collagen hydrolyzate
Prior art date
Application number
AT03759947T
Other languages
English (en)
Inventor
Nicolas Auriou
Michael Beer
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Application granted granted Critical
Publication of ATE502644T1 publication Critical patent/ATE502644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AT03759947T 2002-06-13 2003-06-12 Verwendung von kollagen-hydrolysat zur reduktion der viskosität einer guarkernmehl enthaltenden zusammensetzung ATE502644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213612.5A GB0213612D0 (en) 2002-06-13 2002-06-13 Organic compounds
PCT/EP2003/006194 WO2003105882A1 (en) 2002-06-13 2003-06-12 Composition comprising viscous fibers and viscosity-lowering proteins

Publications (1)

Publication Number Publication Date
ATE502644T1 true ATE502644T1 (de) 2011-04-15

Family

ID=9938524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03759947T ATE502644T1 (de) 2002-06-13 2003-06-12 Verwendung von kollagen-hydrolysat zur reduktion der viskosität einer guarkernmehl enthaltenden zusammensetzung

Country Status (13)

Country Link
US (1) US20060099324A1 (de)
EP (1) EP1515741B1 (de)
JP (2) JP2005534667A (de)
AT (1) ATE502644T1 (de)
AU (1) AU2003242692C1 (de)
CA (1) CA2489250C (de)
DE (1) DE60336472D1 (de)
DK (1) DK1515741T3 (de)
ES (1) ES2363220T3 (de)
GB (1) GB0213612D0 (de)
PT (1) PT1515741E (de)
WO (1) WO2003105882A1 (de)
ZA (1) ZA200409528B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10331202A1 (de) * 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
WO2005036971A1 (en) 2003-10-16 2005-04-28 Techcom Group, Llc Reduced digestible carbohydrate food having reduced blood glucose response
US8227008B1 (en) * 2003-10-22 2012-07-24 Cybersoft, Inc. Low carbohydrate, functional-like foods and systems incorporating same
US7879380B1 (en) * 2003-10-22 2011-02-01 Cybersoft, Inc. Apparatus, methods and articles of manufacture for high conductivity cooking
EP1753443A1 (de) * 2004-05-27 2007-02-21 Campina Nederland Holding B.V. Verwendung von proteinhydrolysaten zur herstellung eines medikaments zur prophylaxe und/oder behandlung einer dpp-iv-vermittelten erkrankung
US8501676B2 (en) * 2004-07-19 2013-08-06 N.V. Nutricia Preparation for use of aspartate for regulating glucose levels in blood
US20060105021A1 (en) * 2004-09-24 2006-05-18 Remington Direct Lp Cholesterol-reducing liquid
WO2006053761A2 (en) * 2004-11-19 2006-05-26 Dsm Ip Assets B.V. Modified plant gums for preparations of active ingredients
KR101331777B1 (ko) 2004-12-23 2013-11-21 캄피나 네덜란드 홀딩 베.붸. Ｄｐｐ-ｉｖ를 억제하는 펩타이드가 풍부한 단백질가수분해물 및 이의 용도
JP2009517464A (ja) 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
DE102006036285A1 (de) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
FI122915B (fi) * 2006-09-06 2012-08-31 Cerefi Oy Kylläisyyttä aiheuttava tuote
IN2014DN03102A (de) 2006-11-07 2015-07-10 Procter & Gamble
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
FR2912607B1 (fr) * 2007-02-20 2009-10-02 Gervais Danone Sa Produit alimentaire semi-fluide comprenant des fibres de beta-glucane et de la gomme de guar, utilisation en tant qu'aliment fonctionnel
JP2010018522A (ja) * 2007-03-23 2010-01-28 Hiroshima Univ アディポネクチン産生促進剤
US8518469B2 (en) * 2007-06-12 2013-08-27 Kraft Foods Group Brands Llc Powdered beverage composition
FR2917948B1 (fr) * 2007-06-29 2010-10-29 Gervais Danone Sa Preparation de fruits stable a forte concentration de gomme d'acacia
JP5456246B2 (ja) * 2007-09-19 2014-03-26 太陽化学株式会社 腹持ち向上食品及びペットフード
WO2011053786A2 (en) * 2009-10-31 2011-05-05 Solae, Llc Gluten free structured protein product
WO2011112074A1 (en) * 2010-03-11 2011-09-15 N.V. Nutricia Novel glucose tolerance test and composition for use
US9034342B2 (en) * 2010-03-25 2015-05-19 Gateway Health Alliances, Inc Methods and compositions to reduce fat gain, promote weight loss in animals
NZ602949A (en) * 2010-04-12 2014-11-28 Esm Holdings Llc Methods for treating glucose metabolic disorders
WO2012024270A1 (en) * 2010-08-17 2012-02-23 Abbott Laboratories Nutritional composition comprising cereal beta-glucan and salacia extract
AU2013204801B2 (en) 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
EP2700321A1 (de) * 2012-08-24 2014-02-26 Etablissements J. Soufflet Wässrige Lebensmittelzusammensetzung angereichert mit Beta-Glucan
TW201501653A (zh) * 2013-03-07 2015-01-16 Otsuka Pharma Co Ltd 含大麥粉末之食品
JP5794373B1 (ja) * 2014-10-28 2015-10-14 不二製油株式会社 肉様食感の強い組織状大豆蛋白質素材
CN106659189B (zh) * 2014-06-10 2023-08-25 不二制油集团控股株式会社 肉般的食感强烈的组织状大豆蛋白质原材料
CN105341561A (zh) * 2014-08-18 2016-02-24 塔特和莱利瑞典公司 具有改善口感的降脂肪组合物
CA2959350A1 (en) * 2014-08-27 2016-03-03 Fmc Corporation Improved drink stabilizer composition and stabilized drink compositions
JP5746414B1 (ja) * 2014-11-25 2015-07-08 森永製菓株式会社 麺様ゲル状食品用の麺線付着防止剤及び麺様ゲル状食品
CA2967284C (en) 2014-11-26 2023-04-04 Inqpharm Group Sdn Bhd A dietary fibre composition
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
CN105982038A (zh) * 2015-02-09 2016-10-05 可口可乐公司 用于再造粒的组合物和方法
JP2016154461A (ja) * 2015-02-23 2016-09-01 味の素ゼネラルフーヅ株式会社 粉末状組成物及びスムージー様飲料
US20160346349A1 (en) * 2015-05-30 2016-12-01 Albert BURGIN Preparation and use of a protein-enriched soluble fiber composition
US10226063B2 (en) * 2015-10-01 2019-03-12 The United States Of America As Represented By The Secretary Of Agriculture Methods of decreasing the viscosity of a dietary fiber
EP3167895A1 (de) * 2015-11-10 2017-05-17 University College Dublin Nahrungsergänzung enhaltend beta-glukan und caseinhydrolysat zur verbesserung des gesundheits- und wachstumsleistung in einem säugetier
ITUA20163937A1 (it) * 2016-05-30 2017-11-30 Pharcoterm S R L Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.
WO2021037767A1 (en) * 2019-08-23 2021-03-04 Société des Produits Nestlé S.A. Thickeners and nutritional products to promote safe swallowing for individuals with dysphagia and methods of making and using same
IT202100008693A1 (it) * 2021-04-07 2022-10-07 Alessandro Longhin Crema alimentare spalmabile salata, nonche’ semilavorato e metodo per la preparazione della stessa
WO2023190293A1 (ja) * 2022-03-30 2023-10-05 ニュートリー株式会社 とろみ状栄養組成物
US20250212926A1 (en) * 2022-05-12 2025-07-03 The Live Green Group, Inc., Plant-only gums (3) replacement system in food products and methods of preparation thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3889007A (en) * 1973-01-26 1975-06-10 Ocean Food Inc Aquatic animal food composition
GB2021948A (en) * 1978-05-30 1979-12-12 Speywood Lab Ltd Water miscible gum composition and its preparation and use
ES482790A0 (es) * 1978-07-25 1980-11-01 Wellcome Found Un procedimiento para obtener una formulacion de goma de polisacarido terapeuticamente util
JPS56169560A (en) * 1980-05-30 1981-12-26 Tanpei Seiyaku Kk Dietary food
US4478658A (en) * 1982-12-20 1984-10-23 Warner-Lambert Company Method for sealing non-enteric capsules
AU598588B2 (en) * 1986-09-01 1990-06-28 Terumo Kabushiki Kaisha Food composition
JPS63185339A (ja) * 1986-09-01 1988-07-30 Terumo Corp 食品用組成物
EP0483070B1 (de) * 1990-10-24 1995-04-12 Novartis Nutrition AG Vollwertnahrung aus hydrolysierten löslichen Faserstoffen
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5545411A (en) * 1994-12-16 1996-08-13 Bristol-Myers Squibb Company Method for lowering viscosity by use of gum acacia
JPH104876A (ja) * 1996-06-19 1998-01-13 Calpis Food Ind Co Ltd:The カルシウム入り乳性酸性飲料
JP3720496B2 (ja) * 1996-11-29 2005-11-30 ユニテックフーズ株式会社 新規ペクチン及びそれを含有する乳化液
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
BR9809046A (pt) * 1997-03-13 2000-08-01 Abbott Lab Fórmula nutricional contendo proteìna hidrolisada e uma mistura de fibras
CN1108149C (zh) * 1997-03-18 2003-05-14 新时代株式会社 固体微粒形成用组合物
ES2221014T3 (es) * 1997-06-23 2004-12-16 Societe Des Produits Nestle S.A. Composicion nutritiva que contiene fibras de guisante e inulina.
DE69818594T2 (de) * 1997-06-23 2004-09-23 Société des Produits Nestlé S.A. Verwendung einer nutritiven Zusammensetzung zur Herstellung einer flüssigen Zusammensetzung für Diabetiker
CA2252691C (en) * 1997-11-07 2005-12-06 Kyowa Hakko Kogyo Co., Ltd. Protein-containing acidic foods and drinks
US6210686B1 (en) * 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US6355609B1 (en) * 1999-04-14 2002-03-12 Nestec S.A. Methods for stabilizing liquid nutritional products and products so stabilized
JP4620819B2 (ja) * 1999-08-25 2011-01-26 味の素株式会社 高カロリー高蛋白質流動食
JP2001120227A (ja) * 1999-10-29 2001-05-08 We'll Corporation:Kk ダイエット食品
AU2437101A (en) * 1999-12-16 2001-06-25 Harry Siskind Nutritional composition, methods of producing said composition and methods of using said composition
JP3907098B2 (ja) * 2001-02-13 2007-04-18 株式会社大塚製薬工場 栄養飲料またはゼリー

Also Published As

Publication number Publication date
HK1075012A1 (en) 2005-12-02
GB0213612D0 (en) 2002-07-24
EP1515741A1 (de) 2005-03-23
DE60336472D1 (de) 2011-05-05
CA2489250C (en) 2013-12-10
AU2003242692A1 (en) 2003-12-31
CA2489250A1 (en) 2003-12-24
ZA200409528B (en) 2006-01-25
JP2005534667A (ja) 2005-11-17
DK1515741T3 (da) 2011-07-11
EP1515741B1 (de) 2011-03-23
PT1515741E (pt) 2011-06-30
US20060099324A1 (en) 2006-05-11
JP2010254702A (ja) 2010-11-11
AU2003242692C1 (en) 2009-06-04
WO2003105882A1 (en) 2003-12-24
ES2363220T3 (es) 2011-07-27

Similar Documents

Publication Publication Date Title
ATE502644T1 (de) Verwendung von kollagen-hydrolysat zur reduktion der viskosität einer guarkernmehl enthaltenden zusammensetzung
PT1112275E (pt) Novos inibidores heteroaromaticos da frutose-1,6-bisfosfatase
DE60043229D1 (de) Zusammensetzung zur gefässbeschichtung
BRPI0410348A (pt) compostos e usos dos mesmos na modulação de amilóide-beta
PT1349856E (pt) Compostos de isoindolina-1-ona activadores da glicocinase
BR9913517A (pt) Composição, dispositivo, e, uso de uma composição
WO2003018752A3 (en) An organotypic intestinal culture and methods of use thereof
ATE250867T1 (de) Verwendung einer nutritiven zusammensetzung zur herstellung einer flüssigen zusammensetzung für diabetiker
DE602004025507D1 (de) Vanillin-polymere zwecks verwendung zur verdunklung der haut
ATE549039T1 (de) Verfahren zur herstellung einer sterilen vorrichtung
PT1007110E (pt) Metodos de aplicacao de composicoes monomericas eficazes como dispositivos de fecho de feridas
DE60238895D1 (de) Zusammensetzung zur Färbung von Keratinfaser, die spezielle Aminosilikonen enthält
HK1049841A1 (zh) 新瞵酸二酰胺药物前体
DE69521623D1 (de) Zusammensetzung für die stabilisation von zahnprothesen
AU4553201A (en) Novel aryl fructose-1,6-bisphosphatase inhibitors
DE69331045D1 (de) Verwendung von igf-1
DE69900485D1 (de) Kosmetische Zusammensetzung enthaltend ein Polysaccharid und ein acrylisches Terpolymer und Verwendung dieser Zusammensetzung zur Behandlung von Keratinfasern
WO2000030667A3 (en) Compositions and methods using lactadherin or variants thereof
EP0942284A3 (de) Gebrauchsfertiges Prothrombinzeitreagenz auf der Basis von rekombinantem Gewebsfaktor
DE602006018175D1 (de) Verfahren zur verwendung von dentalzusammensetzungen mit fluoreszierenden mitteln
DE60312004D1 (de) Zusammensetzungen enthaltend mindestens kürbisöl und borretschöl, deren verwendung als arzneimittel, dermatikum oder dermatokosmetische zusammensetzung
DE69402951D1 (de) Kombinierten Polymere zur Verwendung in künstlicher Tränenflussigkeit
Correr-Sobrinho et al. Effect of experimental resin cements containing thio-urethane oligomers on the durability of ceramic-composite bonded interfaces
Alvares et al. Silicone index: an alternative approach for tooth fragment reattachment
DE60140864D1 (de) Therapeutische zusammenfassungen und verfahren zur modulierung von v3, eine isoform von versican

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1515741

Country of ref document: EP